Quantitative multiplex real-time PCR for the sensitive detection of interferon β gene induction and viral suppression of interferon β expression

Cytokine

Volumn 24, Issue 5, 2003, Pages 190-200

  Richtsteiger, Ralf ^a   Henke Gendo, Cornelia ^a   Schmidtke, Michaela ^b   Harste, Gabriele ^a   Heim, Albert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Coxsackievirus B3; Interferon beta; Multiplex PCR; Poly I:C transfection; Quantitative PCR

Indexed keywords

BETA INTERFERON; MESSENGER RNA; POLYCYTIDYLIC ACID; PORPHOBILINOGEN DEAMINASE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; FIBROBLAST; GENE INDUCTION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REDUCTION; REPRODUCIBILITY;

COXSACKIEVIRUS;

EID: 0142164889     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.09.001     Document Type: Article

References (49)

1. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev. 14:2001;778-809.
2. Lee B.N., Hammill H., Popek E.J., Cron S., Kozinetz C., Paul M., et al. Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women. Infect Dis Obstet Gynecol. 9:2001;95-104.
3. Heim A., Grumbach I.M., Zeuke S., Top B. Highly sensitive detection of gene expression of an intronless gene: amplification of mRNA, but not genomic DNA by nucleic acid sequence based amplification (NASBA). Nucleic Acids Res. 26:1998;2250-2251.
4. Förster V.T. Zwischenmoleculare Energiewanderung und Fluoreszenz. Ann Phys (Leibzig). 1948;55-75.
5. Wittwer C.T., Herrmann M.G., Moss A.A., Rasmussen R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 22:1997;130-131. 134-8.
6. Feldman A.M., McNamara D. Myocarditis. N Engl J Med. 343:2000;1388-1398.
7. Heim A., Stille-Seigener M., Pring-Akerblom P., Grumbach I., Brehm C., Kreuzer H., et al. Recombinant interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts. J Interferon Cytokine Res. 16:1996;283-287.
8. Black T.L., Barber G.N., Katze M.G. Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA. J Virol. 67:1993;791-800.
9. Black T.L., Safer B., Hovanessian A., Katze M.G. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol. 63:1989;2244-2251.
10. Dodd D.A., Giddings T.H. Jr., Kirkegaard K. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol. 75:2001;8158-8165.
11. Doedens J.R., Giddings T.H. Jr., Kirkegaard K. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol. 71:1997;9054-9064.
12. Etchison D., Milburn S.C., Edery I., Sonenberg N., Hershey J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem. 257:1982;14806-14810.
13. Hansen J., Etchison D., Hershey J.W., Ehrenfeld E. Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells. J Virol. 42:1982;200-207.
14. Joachims M., Van Breugel P.C., Lloyd R.E. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol. 73:1999;718-727.
15. Heim A., Zeuke S., Weiss S., Ruschewski W., Grumbach I.M. Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Circ Res. 86:2000;753-759.
16. Mensink E., van de Locht A., Schattenberg A., Linders E., Schaap N., Geurts van Kessel A., et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol. 102:1998;768-774.
17. Landt O. Selection of hybridization probes for real-time quantification and genetic analysis. Meuer S., Wittwer C., Nakagawara K. Rapid cycle real-time PCR: methods and applications. 2001;35-41 Springer-Verlag, Berlin, Heidelberg, New York.
18. Schütz E., von Ahsen N. Spreadsheet software for thermodynamic melting point prediction of oligonucleotide hybridization with and without mismatches. Biotechniques. 27:1999;1218-1224.
19. Jacobs B.L., Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:1996;339-349.
20. Der S.D., Lau A.S. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci U S A. 92:1995;8841-8845.
21. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res. 17:1997;503-524.
22. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B.R. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A. 91:1994;6288-6292.
23. Bonnet M.C., Weil R., Dam E., Hovanessian A.G., Meurs E.F. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol. 20:2000;4532-4542.
24. Mellits K.H., Kostura M., Mathews M.B. Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function. Cell. 61:1990;843-852.
25. Mathews M.B., Shenk T. Adenovirus virus-associated RNA and translation control. J Virol. 65:1991;5657-5662.
26. Elia A., Laing K.G., Schofield A., Tilleray V.J., Clemens M.J. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 24:1996;4471-4478.
27. Azzam-Smoak K., Noah D.L., Stewart M.J., Blum M.A., Sherry B. Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology. 298:2002;20-29.
28. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 18:1998;2986-2996.
29. Schafer S.L., Lin R., Moore P.A., Hiscott J., Pitha P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem. 273:1998;2714-2720.
30. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1998;1087-1095.
31. Chu W.M., Ostertag D., Li Z.W., Chang L., Chen Y., Hu Y., et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity. 11:1999;721-731.
32. Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., Um S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem. 275:2000;6764-6769.
33. Um S.J., Rhyu J.W., Kim E.J., Jeon K.C., Hwang E.S., Park J.S. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett. 179:2002;205-212.
34. Ludwig S., Wang X., Ehrhardt C., Zheng H., Donelan N., Planz O., et al. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol. 76:2002;11166-11171.
35. Talon J., Horvath C.M., Polley R., Basler C.F., Muster T., Palese P., et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol. 74:2000;7989-7996.
36. Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.
37. Oumard A., Hennecke M., Hauser H., Nourbakhsh M. Translation of NRF mRNA is mediated by highly efficient internal ribosome entry. Mol Cell Biol. 20:2000;2755-2759.
38. Finke J., Fritzen R., Ternes P., Lange W., Dolken G. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques. 14:1993;448-453.
39. Chretien S., Dubart A., Beaupain D., Raich N., Grandchamp B., Rosa J., et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci U S A. 85:1998;6-10.
40. Lupberger J., Kreuzer K.A., Baskaynak G., Peters U.R., le Coutre P., Schmidt C.A. Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes. 16:2002;25-30. [doi: 10.1006/mcpr.2001.0392].
41. Fiers W., Remaut E., Devos R., Cheroutre H., Contreras R., Gheysen D., et al. The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells. Philos Trans R Soc Lond B Biol Sci. 299:1982;29-38.
42. Havell E.A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 2:1972;476-484.
43. Schenborn E. Tfx-50 reagent: a new transfection reagent for eucaryotic cells. Promega Notes. 52:1995;2.
44. Li X.L., Boyanapalli M., Weihua X., Kalvakolanu D.V., Hassel B.A. Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents. J Interferon Cytokine Res. 18:1998;947-952.
45. Harms W., Rothamel T., Miller K., Harste G., Grassmann M., Heim A. Characterization of human myocardial fibroblasts immortalized by HPV16 E6-E7 genes. Exp Cell Res. 268:2001;252-261. [doi: 10.1006/excr.2001.5274 ].
46. Schmidtke M., Selinka H.C., Heim A., Jahn B., Tonew M., Kandolf R., et al. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology. 275:2000;77-88. [doi: 10.1006/viro.2000.0485].
47. Heim A., Brehm C., Stille-Siegener M., Muller G., Hake S., Kandolf R., et al. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon- alpha 2a in carrier-state coxsackievirus B3 replication. J Mol Cell Cardiol. 27:1995;2199-2208.
48. Wittwer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., Balis U.J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques. 22:1997;176-181.
49. Ririe K.M., Rasmussen R.P., Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem. 245:1997;154-160.